To be honest, I feel that Monnica Williams is better positioned to answer this question. However, briefly, over the last 12 years, the evidence on psilocybin applications for therapeutic use has really blossomed. There is a growing number of papers and an enormous amount of evidence now suggesting that psilocybin is performing well in clinic trials. The American FDA has identified psilocybin as a breakthrough therapy for the treatment of major depression disorders and for post-traumatic stress disorders.
On February 6th, 2024. See this statement in context.